Iwate, Japan

Makiko Ebata

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Biococoon Laboratories, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Makiko Ebata. Retrieved from https://idiyas.com/inventor/makiko-ebata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Makiko Ebata: Inventor of a Cyclic Peptide Derivative

Introduction

Makiko Ebata is an inventor associated with Iwate, Japan. Her patent work includes a cyclic peptide derivative described as having astrocyte proliferative activity, as well as a salt of that derivative.

Latest Patents

The available information lists one patent for Makiko Ebata: “Cyclic Peptide Derivative, Method for Preparing Same and Composition Thereof.” The invention concerns a cyclic peptide derivative with astrocyte proliferative activity, or a salt thereof, and also addresses methods for preparing the derivative and compositions containing it. 1 patent

Career Highlights

Ebata is associated with Biococoon Laboratories, Inc. and Lotte Co., Ltd. The provided information does not specify her roles or the dates of her work with these companies.

Collaborations

Mayumi Karimazawa and Koichi Suzuki are identified as Ebata’s coworkers. The available details do not specify their roles in the patent or related research.

Conclusion

Makiko Ebata’s listed patent focuses on a cyclic peptide derivative with astrocyte proliferative activity, reflecting her documented contribution to invention and patent development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…